Cancer cure: Glowing dye makes tumors visible during surgery
Researchers have developed a new potential cancer cure: Targeting tumor cells with glowing dye to improve the success of surgery.
Stay updated with breaking news from Molecular Imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have developed a new potential cancer cure: Targeting tumor cells with glowing dye to improve the success of surgery.
/PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, released preclinical data of its NTSR1-targeting RDC...
Addresses all clinical needs, including oncology, theranostics, cardiology, and neurology
The scientists and surgeons at the University of Oxford in collaboration with the California-based biotech company ImaginAb Inc. have developed a glowing dye to identify cancerous tissue, enabling surgeons to completely eradicate the disease.
A new ultra-high-performance brain PET system allows for the direct measurement of brain nuclei as never before seen or quantified. With its ultra-high sensitivity and resolution, the NeuroEXPLORER provides exceptional brain PET images and has the potential to spur advances in the treatment of many brain diseases. This research was presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, and the grouping of images highlighting targeted tracer uptake in specific brain nuclei has been selected as the 2024 SNMMI Henry N. Wagner, Jr., Image of the Year.